贝达药业：产品恩沙替尼已在美国正式商业化落地

Group 1 - The core point of the article is that Betta Pharmaceuticals has successfully commercialized its product Ensartinib in the United States and is actively advancing its sales efforts [2] - The company has established the necessary teams in accordance with regional regulations and business practices for sales operations [2] - Betta Pharmaceuticals will promptly disclose any significant commercial cooperation matters through announcements or its public platform [2]